Health Care Equipment & Services

UnitedHealth Group’s 2026 rise to a 52‑week high is driven by transparent MA pricing, tighter cost control, and robust Optum growth, boosting revenue, margins, and quality metrics.

European markets end the week on modest gains as strong earnings lift key indices, yet sector‑specific risks and geopolitical tensions temper optimism.

Explore how Sonic Healthcare’s diagnostics role shapes the State Street SPDR S&P ASX 50 ETF—margin trends, regulatory impacts, digital opportunities, and hidden risks revealed.

Humm Group’s board stays unchanged, while a $22 M legal settlement with SMBC clears a major liability, giving investors confidence and a modest share‑price lift.

Steris plc’s 2026 results show steady revenue growth and a 18.4% operating margin, amid tariff pressures and rising competition. Capital‑spending and a $1B buy‑back program boost future upside, but regulatory tightening and digital‑sterilization ent…

Siemens Healthineers’ Q1 slump shows a €1.7 bn profit drop and a €0.4 bn loss, but AI‑driven imaging and digital health R&D still drive future growth potential.

UnitedHealth’s shift to flat‑fee pharmacy pricing boosts earnings stability, offers clearer costs for members, and positions Optum Rx ahead of competitors in a cost‑sensitive market.

European equity markets fell modestly amid Middle‑East tensions and higher oil prices, but Fresenius Medical Care outperformed, showing healthcare’s resilience amid inflationary pressure.

Zimmer Biomet boosts its FY‑2026 buyback target to $1B, balancing cash flow, regulatory hurdles and competitive pricing to enhance shareholder value.

Wells Fargo cuts Cencora’s target after Lasix ONYU launch: learn why the drug‑device combo’s pricing, regulatory risks and at‑home care trend drive a 12% hit to investor upside.